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Results of Animal Studies Suggest a 
Nonlinear Dose-Response Relationship for 
Benzene Effects 
·~ . 
by S, Parodi,* W. K. Lutz,t A. Colacci,* M. Mazzullo,:t: 
M. Taningher,* and S. Grilli* 
Considering the very large industrial usage of benzene, studies in risk assessment aimed at the evaluation 
of carcinogenic risk at low Ievels of exposure are important. Animal data can offer indications about what 
could happen in humans and provide more diverse information than epidemiological data with respect to dose-
response consideration. We have considered experiments investigating metabolism, short·term genotoxic-
ity tests, DNA adduct formation, and carcinogenicity long-term tests. According to the different experiments, 
a Saturation of benzene metabolism and benzene effects in terms of genotoxicity seems evident above 30 to 
100 ppm. Below 30 to 60 ppm the initiating effect ofbenzene seems tobe linear fora large intervaJ ofdosages, 
at least judging from DNA adduct formation. Potentiallack of a promoting effect of benzene (below 10 ppm) 
could generate a sublinear response at nontox.ic levels of ex.posure. This possibility was suggested by epidemio-
logical data in humans and is not confirmed or excluded by our observations with animals. 
·lntroduction 
Benzene is one of the chemieals with the largest indus-
trial production in the world. Production of benzene of all 
grades in 1980 in the U.S. totaled more than 5 million tons 
(1). Millions of tons of benzene were also produced in Eu-
rope, the USSR, and Japan. Because of its presence in 
many fuels and as a contaminant in many organic chemi-
eals and solvents, it has been estimated that in 1980 about 
2 million workers were pote11tially exposed by benzene 
in the U.S. alone (1). 
As is reasonable to expect, epidemiological data show 
very small tumor incidences at low levels of exposure (for 
instance clearly below 30 ppm of average exposure dur· 
ing a working day). Most epidemiological evidence seems 
to concern levels of exposure roughly in the order of 30 
ppm and higher (2). In a very recent paper by Rinsky et 
al. (3), an attempt was made to investigate the relative 
risk in humans for Ievels of exposure lower than 10 ppm 
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over a 40-year working lifetime. Only tht·ee to four ca.ses 
in excess of the number expected were observed in this 
low range. In this situation it is difficult to establish, on 
the basis of epidemiological data alone, a type of dose-; *' 
response relationship allowing extrapolations of tumor in- ~ 
cidences at 10 ppm or 1 ppm (average exposure during ;: 
a work day). 
We were interested in investigating the Situation in 
small rodents. For small rodents, data are available that 
can allow the construction of dose·response relationships 
for several types of parameters: production of metabo-
lites, formation of DNA adducts, response to tests of 
genotoxicity, [chromososmal damage, micronuclei induc-
tion, induction of sister chromatid exchanges (SC Es)], and 
also 1ong-term experiments of carcinogenicity. 
Formation ofmetabolites, formation of DNA adducts, 
and response to tests of genotoxicity give infonnation 
mainly about the initiating potential ofbenzene. When tu-
mor formation in long-term experiments is examined, we 
see the effects of benzene both on initiation and promo-
tion. Toxicity (for instance, hone marrow toxicity) and 
compensatory cell regeneration could have a significant 
promoting effect. Unfortunatel~'l!we were unable to find 
studies that investigated the pure promoting activity of 
benzene. . .. 
In spite of the Iack of information about the promoting 
activity of benzene, the animal data about benzene re-
main much richer than epidemiological data; in particu-
lar, many more Observationsare possible about dose-
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response relationships. In this paper we have tried to in-
vestigate at different levels of exposure animal data 
about benzene, specifically in the perspective of what 
th~se data can suggest in terms of dose-response relation-
ships. As a general trend, the results seem to point in the 
direction of a saturation of metabolism and probably of 
th~ initiating potential of benzene above 30 to 50 ppm. 
Th1s could confirm some epidemiological data conceming 
high Ievels of exposure. 
Epidemiological Data 
It is difficult to establish a dose-response relationship 
between level, frequency, and duration of benzene ex-
posure and increased risk of leukemia. Three papers are 
available, dealing with similar Ievels of exposure and simi-
lar Jeve1s of increased risk. In a paper by Ott et al. (4) 
workers were exposed to ranges between 1 and 30 ppm 
of benzene (per work day) for approximately 8 to 9 years. 
This gave a relative risk of myelogenous leukemia of 3. 75. 
In a paper hy Rinsky et al. (3) cases were exposed to 
an average of 24 ppm of benzene per work day for an 
average duration of 8. 7 years. The standardized mortal-
ity ratio for leukemia was 3.37. In a paper by Yin et al. 
(5) cases were exposed to a median value of 28.4 ppm per 
work day for an average time that can be roughly esti-
mated around 9 years. The standardized mortality ratio 
for leukemia was 5. 7 4. 
It is difficult to normalize completely data from differ-
ent papers, and the concordance among the data from the 
three different papers that we have previously mentioned 
can already be considered rather good. 
In a paper by Vigliani (6), higher levels of exposure 
were considered. Cases were exposed to 200 to 500 ppm 
of benzene per work day for an average length of ex-
posure of about 16 years. According to the author, the 
risk of leukemia was at least 20 times high er than for the 
general population. Because in this ease the Ievel of ex-
posure was at least 10 times the Ievel of exposure 
reported in the three previous works and the length of 
exposure was about twice, we could expect a relative risk 
much higher than 20 (perhaps around 50-90). lt is diffi-
cult to say if this nonlinear relationship reflects a flatten· 
ing out of the response above 30 ppm and 8 years of aver-
age length of exposure, or if it is simply related to an 
imperfect compatibility of the data. 
What about levels of exposure below 30 ppm per work· 
ing day? Rinsky et aJ. (3) have suggested that below the 
equivalent of 10 ppm over a 40-year working lifetime, the 
dose-response relationship could be sublinem·. The nurn-
ber of cases on which this suggestion is based is too small 
to reach a clear statistical significance; however, in our 
opinion, this suggestion is intriguing for the following rea-
son. It has been observed by Yin et al. (5) that leukemia 
mortality among benzene poisoning cases was 49 times 
that in benzene workers. . 
It is quite possible that cell death and compensatory cell 
regeneration in hone marrow cells could have a promot~ 
ing effect in benzene leukemogenesis. If benzene is a com· 
plete carcinogen because it is endowed with both initiat-
ing and promoting activity, the combination of the two 
effects could generate the type of curve hypothesized by 
Rinsky et al. (3) in the low range of benzene exposure. 
In summary, the dose-response of the leukemia inci-
dence curve for benzene could be a sigmoid curve that 
flattens out at Ievels of exposure above 50 to 100 ppm per 
work day and is perhaps sublinear at levels of exposure 
below 10 to 30 ppm (Table 1). 
Metabolism of Benzene in Rodents 
The dose-response relationship for benzene metabolism 
seems to depend, as is reasonable to expect, on the Ievel 
of exposure. Jongeneelen et al. (7) have exposed male 
Wistar rats for 8 hr to inhalation of 0, 7.5, 10, 13, 21, and 
33 ppm ofbenzene. S-Phenyl·N-acetyl-cysteine and phe-
nol were determined in the 24-hr urine of the exposed 
rats. The dose-response relationship was linear for both 
metabolites, suggesting that in rats, nonsignificant satu-
ration of benzene metabolism is present for a level of in-
halation exposure lower than 30 ppm. 
The Situation seems to be different for higher levels of 
exposure. Ulanova and Avilova (8) have shown that the 
content of phenol in the urine of rats after a single 4-hr 
inhalation exposure increases much more slowly than the 
exposure level for levels of exposure above 100 mg/m3 
( rv30 ppm), suggesting a progressive saturation of metab-
olism ahove this concentration. Similarly, Grilli et al. (9) 
have found, using a closed inhalation chamber, that me-
tabolisrn of henzene in the chamber foHowed essentialJy 
zero-order kinetics above 50 ppm (at equilibrium between 
rat and chamber), and tirst-order kinetics below 50 to 30 
ppm. Zero-order kinetics is equivalent to saturation of 
metabolism. 
In a different experiment, rats exposed for 6 hr toben-
zene concentrations of 125, 250, 625, or 1250 ppm ex-
creted similar amounts of phenol in urine (10). Even in 
this experiment benzene metaboJism was already satu-
rated above 100 ppm. 
Sabourin et al. (11) showed an increased amount of un-
metabolized benzene in air above 130 ppm in B6C3F 1 
mice and F344/N rats after 6-hr inhalation exposure. To-
tal production of metabolites in urine and feces was also 
evaluated. Saturation of metabolism was more marked in 
mice than in rats, mainly because absorption was higher 
in mice than in rats because of increased ventilation. The 
Table 1. Summary of quantitative epidemiological data available 
for human occupational exposure to benzene. 
Level of Dose-response 
cxposure Relath·e risk relationship 
Araund 3 ppm, about Linear or 
8 years of exposure (3) IA sublinear 
Around 30 ppm, 8-9 
years of exposure (.'1-S) 3-6 Linear 
At'Ound 200-500 ppm, 
about 16 ycat'S of 
exposure (6) 20 Supralinear? 
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Table 2. Summary of data concerning benzene metabolisrn 
in rodents. 
Level of 
e.xposure 
Up to 30 ppm 
30 ppm and above 
30-50 ppm anrl above 
Above 100 ppm 
Above 130 ppm 
Dose-response 
relationship 
Linear 
Supralinear 
Supralinear 
Supralinear 
Supra1inear 
Refercnce 
(i) 
(8) 
(9) 
(10) 
(11) 
same authors (11) reported a Saturation of benzene me-
tabolism after administration by gavage in both rats and 
mice for dosages above 50 mg/kg. 
In conclusion, benzene metabolism seems to be satu-
rated in rodents at the highest concentrations. Saturation 
seems to start most probably at 30 to 50 ppm (Table 2). 
Short-Term Tests 
Mazzullo et al. (12) have investigated the dose-response 
relationship for DNA adducts in rats after IP acute ad· 
ministration. Liver, kidney, lung, stomach, and spleen 
were investigated. The range of dosages explored was be-
tween 1.04 x 10- 6 and 6.23 mmole/kg. The dose-response 
relationship in liver was strikingly linear from the lowest 
dosage up to 0.623 mmolelkg. A flattening out of the re-
sponse appeared at the highest dosage. 
Grilli et al. (9) have examined the response to benzene 
in 180 different experiments investigating the genotox· 
icity of benzene. The main categories of these tests of 
genotoxicity were DNA darnage and repair, mutations, 
and chromosomal anomalies, including SCEs. 
While tests of mutagenicity were positive in only 24% 
of the cases, tests related to chromosomal alterations 
were positive in 76% of the cases. I t has been suggested 
by Ashby et al. (13) that when large numbers of tests are 
considered for a given chemical, a 20% of positive results 
is more typical of a negative compound and 80% of posi-
tive results is more typical of a clearly positive compound. 
Therefore we have assumed that most typically benzene 
clearly shows its genotoxicity at the chromosomallevel. 
Especially, it is very common to find positive results for 
the induction of micronuclei, chromosome aberrations, 
and SCEs in rodents after treatment with benzene. 
For several experiments conceming micronuclei, chro· 
mosome aberrations, and SCEs, we were able to inves-
tigate the dose-response relationship. The results are 
reported in Table 3. While the experiments considered 
all seem to suggest a flattening out of the response toben-
zene between 10 and 100 ppm, both for micronuclei induc· 
tion, chromosomal anomalies, and SCEs, a paper which, 
to some extent, disagreed with such findings was recently 
published {14). In that paper, the induction of chromatid 
breaks in lymphocytes of mice after subchronic exposure 
to benzene was investigated. Mice were treated daily by 
gavage with 0, 36.6, 73.2, and 146.4 mg/kg ofbenzene for 
2 weeks. Judging from the graph shown by the authors, 
the response was essentially linear. According to EP A 
computations (15,16), 146.4 mglkg con·esponds roughly to 
42 ppm/day. The animals used were Swiss ICR male 
mice. It is difficult to say if the linear response was spe· 
cifically related to the strain used or if a flattening out of 
the response would have appeared above 40 ppm. 
If we accept the idea that the majority of the results 
Table 3. Dose-response relationship for the clastogenic activity of benzene in rodents. 
Route of Effcct~/dosagc ratio at different dosage 
Species aciministration Endpoint and dosc unit Low Medium High 
Male Swiss Oralb Mkronuclei/1000 PCE,c 
mice mg/kg 4-2.4/S.Sd = 0.18 6-2.4/88 = 0.04 28.7-2.4/880 "" 0.03 
Oralb Cht'omosome aberrutions 
per metaph~tse, mg/kf 0.06-0.0:1/8.811 = 0.0034 0.16-0.03/88 = 0.0015 1.1-0.03/880 ::= 0.0012 
Male BflC:3F't Oral" Micronuclei/1000 NCE, 
mice mg/kg 2.5-1.21258 = 0.052 5.8-1.21100 = 0.046 9.3-1.21600 :::: 0.013 
Male Wistar lnhalationh % Cells with chromosome 
rats anomalies, ppm 6 h1· 8.03-1.54/10 = 0.15 4.45-1.54/100 = 0.030 7.81-1.54/1000 ::< 0.0063 
Male DBA/2 Jnhalation1 SCE/metaphase, 
mice ppm 6 hr 7.6-5.9/10 = 0.17 9.5-5.9/100 = 0.036 13.8-5.9/1000 = 0.0079 
Inhalation; Micrunuclei/1000 PCE, 
ppm G hr 9-2.1/10 = 0.67 20.3-2.1/100 = 0.18 28.1-2.1/1000 = 0.026 
Spra~,rue· Dawley Inhalation; SCE/mctaphase, 
rats ppm 6 hr 10.4-8.6/10 = 0.18 11.1-8.6/30 =: 0.083 
Sprague· Dawley Inahalation; Micronuclei/1000 PCE, 
ra~ ppm 6 hr 6.2-2.0/10 = 0.42 7.6-2.0/30 = 0.19 
3 Treated values minus control values. e· 
bTwo doses were administered 24 hr apart and animals were sacrificed !30 hr after the first dose (30). 
cpcE, polychromatic erythrocytes. 
dCorresponding to 3. 76 ppm according to EPA computations (15) assuming a respiratory absorption coefficient of 0.5 and a ventilation capacity 
of 0.03 Llmin for the mousc (16). 
~subchronic trcatment within NTP study (.1?5). Micronuclci were measured after exposure for 5 days/week for 4 months (31). 
rNCE, nonnochromatic erythrocytcs. 
'Corresponding to 10.7 ppm according to EPA computations (1.5), assuming a respiratory absorption coefficient of 0.5 and a ventilation capacity 
of 0.03 L/min for thc mouse (16). 
~Exposure of 6 hr (32). 
'Exposure of 6 hr (83). 
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at the level of chromosomal darnage seem to suggest, in 
the case of benzene, a flattening out of the response above 
30 ppm, we have to show that there are other direct-
acting compounds that generate a linear response over 
a ]arger interval than the interval of response observed 
here. This control is ne~ded to rule out the possibility that 
the responses observed are intrinsically nonlinear in the 
range under scrutiny even for direct-acting compounds. 
Neal and Probst (17) have investigated the induction of 
SCEs in vivo in hamster bone marrow ce11s. A very good 
linearresponsewas observed for mitomycin C (MMC) 
over the whole range of dosages examined and up to 37 
SCEs per metaphase. Linearresponses were also ob-
served for several other compounds like N,N',N"-triethyl-
enethiophosphoramide, hycanthone, busulfan, and 
triethylene melamine with up to 31 SCEs per metaphase. 
Only cyclophosphamide, which is known to require meta-
bolic activation, showed a nonlinear dose response. Car-
rano et al. (18) have shown in vitro in CHO cells a very 
good linear response for MMC and ethyJ methanesul-
fonate (EMS) up to more than 50 SCEs per cell. Because 
in our results (Table 3) the number of SECs per 
metaphase never exceeded 15, the flattening out of the 
response cannot be considered intrinsic to SCE behavior, 
but can be reasonably attributed to the Saturation of ben-
zene metabolism. 
Kliesch et al. (19) have examined the induction of 
micronuclei in vivo in hone marrow cells after treatment 
with doubling dosages of methyl methanesulfonate 
(MMS), MMC, and procarbazine (PC). The response was 
clearly linear for both MMS and MMC with up to 70 to 
80 mic.ronuclei per 1000 poJychromatic erythrocytes 
(PCEs). Only for PC, which required metabolic activa-
tion, was a flattening out of the response observed. 
Similar results have been reported by Aeschbacher 
(20). The number of micronuclei per 1000 PCEs was 
studied in several inbred strains of mice. N-Methyl-
N'-nitro-N-nitrosoguanidine (MNNG), MMC, and MMS 
were investigated. For all three compounds tested, and 
essentially in all the strains examined, micronuclei gave 
a linear response with up to 20 micronuclei for MMNG, 
up to 100 micronuclei for MMC, and up to 50 micronuclei 
for MMS. 
Similar linear responses were also obtained for the in-
duction of micronuclei in vitro. Bonatti et al. (21) exam-
ined the induction of micronuclei in V79 cells. Both ethyl 
nitrosourea (ENU) and EMS induced a linear response 
up to 100 micronuclei per 1000 cells. 
Lasne et al. (22) also examined the induction of 
micronuclei in V79 cells. MNNG, MMS, and EMS were 
examined only at low concentrations. The response was 
perfectly linear for MNNG find EMS and aJmost linear 
for MMS. However, only up to 10 to 15 micronuclei per 
1000 cells were induced at the low concentrations tested. 
If we consider that we observed a flattening out of the 
induction of micronuclei in response to benzene for nuro-
ber of micronuclei below 10/1000 cells, as reported in Ta-
ble 3, it appears that this saturation of the response is not 
intrinsic to the micronuclei indication but rather because 
of the metabolic activation of benzene. Wehave to under-
line that to show the intrinsically linear response of SCE 
and micronucleus induction over a sufficiently large range 
we did not perform any selection whatsoever ofthe avail-
able literature, but just used the first six suitable papers 
available in our files. 
Carcinogenicity in Animals 
Several studies have shown that benzene is a carcino-
gen in mice and rats (23-27). Different organs are affected 
but leukemias are not particularly prominent and are not 
usually of the myeloid type. While the main target organ 
seems to be different in humans and rodents, oncogenic 
potency seems tobe sirnilar in both species. 
Grilli et al. (9) have discussed in detail the notion that 
the ratio of tumor latency to life-span is as a first approx-
imation similar in humans and rodents. Assuming that 
this is so, from the data of Maltoni et al. (fJ6) we can make 
the extrapolation that 100 ppm, 8 hr/day, 5 days a week, 
for 2 years, will induce an overall tumor incidence of 
11111000 rats over controls. 
By applying a similar extrapolation to the data of 
Snyder et al. (24), we obtain an averaU tumor incidence 
of 67/1000 mice over controls (9). It has been estimated 
by the IARC Warking Group (2) that in humans, 100 ppm 
of benzene over a 45-year working lifetime would include 
140 to 170 cases ofleukemia per 1000 exposed workers. 
The order of magnitude of risk estimations in rodents and 
humans appears to be very similar, especially consider-
ing that carcinogenic potencies can span a range of more 
than 107 times (28,29). 
Ifthe quantitative dimension ofthe phenomenon oftu-
mor induction is similar in humans and rodents, it can be 
interesting to Iook at the dose-response relationship of 
cancer incidence in rodents. This dose-response relation-
ship is analyzed in Table 4. This table seems to suggest 
that above 25 ppm [approximate transfonnation in parts 
per million for rats according to (15,16)] cancer incidence 
increases less than proportionally to the dosage. Onco-
genic potency inde·x (OPI), which is essentially incidence 
divided by dosage, seems to decrease by about five times 
when the dosage is increased from about 25 to about 250 
ppm. 
In conclusion, at least the gavage experiments reported 
in Table 4, for which several dosages are available, seem 
to suggest a possible saturation of benzene metabolism 
for the highest dosages. No dose-response relationships 
were available for inhalation experiments. 
Discussion 
Wehaveseen that several data concerningthe produc-
tion and excretion of benzene metabolites in rodents seem 
to suggest some saturation of metabolism for levels of ex-
posure above 30 to 50 ppm.· Except for one paper show-
ing linearity up to the equivalent of 40 ppm, all the papers 
concerning the genotoxicity of benzene (chromosome 
anomalies, SCEs, and micronuclei) showed a flattening 
out of the response starting at Ievels of exposure between 
30 and 100 ppm. 
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Table 4. Oncogenic potency in rodent.s for different dosages of benzene. 
Dosagc, mglkg 
pro d-ie, gavage 
25 
50 
100 
200 
250 
500 
Equivalent dosagc, ppm pro die, 
24-hr inhalationa 
Rats 
27 
5.3 
107 
214 
267 
534 
Mice 
7 
14 
29 
57 
71 
143 
8 Acco1·ding to Lee et al. (15) and Gold et al. (16). 
F344 rat8 (25t 
1.14 
0.82 
0.59 
0.49 
Oncogenic potency inde:<b 
B6C3F, mice (25) 
0.88 
0.56 
0.53 
S-D rats (26) 
0.23 
0.16 
"O:nco~,~nicpotency inde:< asafunction ofdosage ofbenzene in mice andrats =-Ln (1- 1)/Dt, where I is thecxcess incidence ovcrcontrols (proportion 
of animals with at least one ma\lgnant tumor for a\l tumors), t is the length of observation (time unit = 2 years), and Dis the dosage in miUimole 
pel' kilogram per day equivalent to the total close divided hy a 2-year exposure (28). Only dosagcs which produced statistically significant effects 
(p < 0.05) were conside•·ecl. 
cN umbcrs in parentheses are referenccs. 
In a paper by Mazzullo et al. (12), DNA adduct forma-
tion was explored for a very large range of dosages, from 
6.23 x 10- 6 to 6.23 mmole/kg. Saturation of metabolism 
started at the equivalent of 60 ppm, and it was evident 
only in some tissues and macromolecules. 
Below 60 ppm the data were remarkable for the linear-
ity of the dose-response relationship. In three different 
experiments in rats and mice, in which benzene was ad-
ministered chronically by gavage and long-term car-
cinogenicity was investig-ated, a flattening out of the dose-
response relationship was apparent at dosages equivalent 
to 30 to 50 ppm and above. 
Three different epidemiological investigations concern-
ing Ievels of exposure around 30 ppm per work day, for 
an average length of exposure of about 8 to 9 years, are 
quite consistent in suggesting a range of relative risk be-
tween three and six. In a paper by Vigliani (6), higher 
levels and durations of exposure are considered and some 
flattening out of the dose-response relationship seems Ob-
servable. 
In a paper by Rinsky et al. (3), Ievels of exposure be-
low 10 ppm per working day are also considered, and the 
few data available suggest an interesting sublinear re-
sponse. As shown by Yin et al. (5); the risk of leukemia 
is very much increased when benzene toxicity is present. 
This observation suggests a promoting effect ofbenzene 
that could also explain the sublinear dose-response 
reported by Rinsky et al. (3) for Ievels of exposure below 
10 ppm. Indeed, below 10 ppm the promoting effect 
related to benzene toxicity and compensatory cell 
regeneration of hone marrow cells could presumably be 
almost negligible. 
In summary, from DNA adduct data, we have evidence 
that the preliminary step of initiation probably displays 
a linear dose-response relationship even for very low ben-
zene dosages. Above 30 to 50 ppm, metabolism and 
genotoxicity data suggest a flattening out of the initiation 
response. This flattening out of the initiation response is 
also probably detectable in long-tenn carcinogenicity ex-
periments in rodents and perhaps also in the epidemio-
logical data of Vigliani (6). 
Below 10 ppm it could be reasonable to assume a 
negligible promoting effect of benzene (especially a 
negligible clonal expansion of initiated clones). This could 
be in agreernent with the recent epiderniological data of 
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Rinsky et al. (3). A possible final synthesis of the situa-
tion is shown in Figure 1. The effect of benzene is repre-
sented by a sigmoid curve, sublinear below 10 to 30 ppm 
and flattened above 50 to 100 ppm. 
This work was supportcd by grants from Ministero dclla Pubblica Is-
truzi.one and Progetto Finalizzato Oncologia contra.ct Nos. 87.01566.44 
and 87.01315.44, Rome, ltaly. We thank Gabriella Frigerio for her ca.re-
ful typing of the manuscript. 
REFERENCES 
1. IARC. Benzene. Monographs on thc Evaluation of Carcinogenic 
Risk ofChemicals to Humans. Vol. 29. International Agency for 
Research on Cancer, Lyon, France, 1982, pp. 93-148. 
2. IARC. Monographs on the Evaluation of Carcinogenic Risk of 
Chemieals to Hunums, Vol. 29. International Agcncy for Research 
on Cancer. Lyon, France, 1982, pp. ~J:-398. 
3. Rinsky, R..A., Smith, A. B., Hornung, R., Filloon, T. G., Young, 
R. J., Okun, A. H., and Landrigan, P. J. Benzene and leukemia. 
An epidemiologic risk assessment. N. Engl. J. Med. 316: 1044-1050 
(1987). 
4. Ott, M. G., Townsend, J. C., Fishbeck, W. A., and Lungner, R. A. 
Mortality among individua.ls occupational exposed to benzene. 
Arch. Environ. Health 33: 3 (1978). 
176 PARODI ET AL. 
5. Yin, S. N., Li, G. L., Tain, F. D., Fu, Z. I., Chcn, Y. J., Luo, S. J., 
Ye, P. Z., Zhang, J. Z., Wang, G. C., Zhang, X. C., Wu, H. N., and 
Zhong, Q. C. Leukaemia in benzene workers: a retrospective co-
hart study. Br. J. Ind. Med. 44: 124-128 (1987). 
6. Vigliani, E. C. Leukemia associated with bcnzene exposure. Ann. 
N.Y. Acad. Sei. 271: 143-151 (1976). 
7. Jongeneelen, F. J., Dirven, H. A. A. M., Lcijdekkers, C. M., Hen· 
derson, P. T., Brouns, R. M. E., and Halm, K. S-phenyl-N-
acetylcysteine in urine of rats and workers after cxposw·e to ben-
zcne. J. Anal. Toxicol. 11: 100-104 (198"7). 
8. Ulanova, I. P., and Avilova, G. G. Application of toxico-kinetic 
c1iteria as a basis for toxicometric parameters. J. Hyg. Epidemiol. 
Microbiol. Immunol. 31: 113-118 (1987). 
9. Gtilli, S., Lutz, W. K, and Parodi, S. Possible implications from 
results of animal studies in human risk estimations for benzene: 
nonlinear dose-response relatioho~•~tl due to saturation of metab-
olism. J. Cancer Res. Clin. Oncol. 113: 349-358 (1987). 
10. Gut, 1., and Frantik, E. Kinetics ofbenzene metabolism in rats in 
inhalation exposure. Arch. Toxicol. (suppl.) 4: 315-317 (1980). 
11. Sabourin, P. J., Chen, B. T., Lucier, G., Birnbaum, L. S., Fisher, 
E., and Henderson, R. F. Effect of dose on the absorption and ex-
cretion of 14C-benzenc administered orally or by inhalation in rats 
and mice. Toxicol. Appl. Pharmacol. 87: 325-336 (1987). 
12. Mazzullo, M., Bartoli, S., Bonora, B., Colacci, A., Grilli, S., Lat· 
tanzi, G., Niero, A., Turina, M. P., and Parodi, S. Benzene adducts 
\\'ith rat nucleic acids and proteins: dosc-response relationship after 
treatment in vivo. Environ. Health Perspect. 82: 259-266 (1989). 
13. Ashby, J., de Sen·es, F. J., Draper, M., Ishidate, M., Margolin, B. 
M., Matter, B., and Shelby, M. D. Overview and conclusions of the 
IPCS collaborativc study on in vitro assay systems. In: Progress 
in Mutation Research, Vol. 5(J. Ashby, F. J. dc Serres, M. Draper, 
M. Ishidate .• B. H. Margolin, B. E. Matter, and M. D. Shelby, Eds.), 
Elsevier Science Publishers, Amsterdam, 1985, pp. 117-174. 
14. Rithidech, K., Au, W. W., Sadagopa Ramanujam, V. M., Whorton, 
E. G., Jt·., and Legatar, M. S. Induction of chromosome aberrations 
in lymphocytes of mice after subchronic exposure to benzenc. 
Mutat. Res. 188: 135-140 (1987). 
15. Lee, S. D., Dourson, M., Mukcrjee, D., Stara, J. F., and Kawecki, 
J. Assessment ofbcnzene health effects in ambicnt water. In: Ad-
vances in Modern Environmental Toxicology, Vol. 4 (M. A. Meh· 
Iman, Ed.), Princeton Scientitic Publishers, Princeton, NJ, 1983, 
pp. 91-125. 
16. Gold, L. S., Sawyer, C. B., Magaw, R., Backman, G. M., rle Ve-
ciana, M., Levinson, R., Hooper, N. K., Havender, W. R., Bern-
stein, L., Peto, R., Pike, M. C., and Ames, B. N. A carcinogenic 
potcncy database of the standardized results of animal bioassays. 
Environ. Health Perspect. 58: 9-319 (1984). 
17. Neal, S. B., and Probst, G. S. Assessment of sister chromatid ex-
change in spermatongonia and intestinal epithelium in chinesc ham-
sters. In: Sister Chromatid Exhanges: 25 Years of Experimental 
Research, Vol. B (R. R. Tice and A. Hollaender, Eds.), Plenum 
Press, New York, 1984, pp. 613-628. 
18. Carrano, A. V., Thompson, L. H., Lind], P. A., and Minkler, J. L. 
Sister chromatid exchange as an indicator of mutagenesis. Nature 
271: 551-553 (1978). 
19. Kliesh, U., Danford, N., and Adler, I. D. Micronucleus test and 
bonc-marrow chromosome analysis. A comparison of2 methods in 
vivo for evaluating chemically induced chromosomal alterations. 
Mutat. Res. 80: 321-332 (1981). 
20. Aeschbacher, H. U. Rates of micronuclei induction in different 
mause strains. Mutat. Res. 164: 109-115 (1986). 
21. Bonatti, S., Simi, L., and Ahbondandolo, A. The effect of thymi-
dine on the induction of micronuclei by alkylating agents in V79 
Chinesehamster cells. Mutat. Res. 150: 347-353 (1985). 
22. Lasne, C., Gu, Z. W., Venegas, W., and Chouroulinkov, I. Thein 
vitro micronucleus assay for detection of cytogenetic effects in-
duced by mutagen-carcinogens: comparison with the in vitro sister-
chromatid exchange assay. Mutat. Res. 130: 273-282 (1984). 
23. Maltoni, C., and Scarnato, C. First experimental demonstration 
of the carcinogenic effects of benzene. Long-term bioassay on 
Sprcll,rue-Dawlcy rats by oral administraton. Med. Lav. 70:352-357 
(1979). 
24. Snyder, C. A., Goldstein, B. D., Sellakumar, A., Bromberg, 1., 
Laskin, S., and Albert, R. E. The inhalation toxicology ofbenzene: 
incidence ofhematopoietic neoplasms and hematotox.icity in AKR/J 
and C57BL/6J mice. Toxicol. Appl. Pharamcol. 54: 323-331 (1980). 
25. National Toxicology Program. Toxicology and Carcinogenesis 
Studies of Benzenein F344/N Ratsand B6C3Fl mice (Gavage 
Studies). NTP-83-072, NIH publication 84-2545, National Toxicol-
ogy Program, Research Triangle Park, NC, 1986. 
26. Maltoni, C., Conti, B., Cotti, G., and Belpoggi, F. Experimental 
studies on benzene carcinogenicity at the Bologna Institute of On-
cology: current results and ongoing research. Am. J. lnd. Med. 7: 
415-446 (1985). 
27. Cronkite, E. P., Drew, R. T., lnone, T., and Bullis, J. E. Benzene 
hematotoxicity and leukcmogenesis. Am. J. lnd. Med. 7: 447-456 
(1985). 
28. Parodi. S., Taningher, M., and Santi, L. Alkaline elution in vivo: 
Fluorimetric analysis in rats. Quantitative prcdictivity of car-
cinogenicity as compared Ytith other short-term tests. In: lndica-
tot·s of Genotoxic Exposure. Banbury Report 13 (B. A. Bridges, 
B. E. Butterworth, and I. B. Weinstein, Eds.), Cold Spring Har-
bor· Labot·atory, Cold Spring Harbor, NY, 1982, pp. 137-155. 
29. Peto, R., Pike, M. C., Bernstein, L., Gold, L. S., and Ames, B. N. 
Thc TDso: a proposed gcneral convention for the numerical descrip-
tion of the carcinogenic potency of chemieals in chronic-exposure 
animal experiments. Environ. Health Perspect. 58: 1-8 (1984). 
30. Gad-el·Karim, M. M., Harper, B. L., and Legator, M. S. Modifica-
tions in the myeloclastogenic effect ofbenzenc in mice with toluene, 
phenobarbital, 3-methylcholanthrene, Aroclor 1254 and SKF 525-A. 
Mutat. Res. 135: 225-243 (1984). 
31. Choy, W. N., MacGregor, J. T., Shelby, M. D., and Mamopot, R. 
R. Induction of mic:ronuclei by benzene in B6C3F 1 mice: retrospec· 
tive analysis of peripheral blood smears from the NTP carcinogen-
esis bioassay. Mutat. Res. 143: 55-59 (1985). 
32. Styles, J. A., and Richardson, C. R. Cytogenetic effect ofbenzene: 
Dosimetrie studies on rats exposerl to benzene vapour. Mutat. Res. 
135: 203-209 (1984). 
33. Erexson, G. L. Wilmer, J. L., Steinhagen, W. H., and Kligennan, 
A. D. Induction of cytogenctic darnage in rodents after short-term 
inhalation of benzene. Environ. Mutag. 8: 29-40 (1986). 
